EMB-01 is under investigation in clinical trial NCT03797391 (A Dose Escalation Study of EMB-01 in Participants With Advanced/metastatic Solid Tumors).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.